Plasma storage at -80 degrees C does not protect matrix metalloproteinase-9 from degradation.
about
Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysisNitrogen biobank for cardiovascular research.Serum metalloproteinase-9 is related to COPD severity and symptoms - cross-sectional data from a population based cohort-study.Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal populationBiomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: cohort study.Relations of biomarkers of extracellular matrix remodeling to incident cardiovascular events and mortality.Imbalances between matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in maternal serum during preterm laborEffects of preanalytic variables on circulating microRNAs in whole blood.Plasma Matrix Metalloproteinase-9 Levels Predict First-Time Coronary Heart Disease: An 8-Year Follow-Up of a Community-Based Middle Aged Population.Adsorbing/dissolving Lyoprotectant Matrix Technology for Non-cryogenic Storage of Archival Human SeraPre-analytical stability of the plasma proteomes based on the storage temperature.Banking of biological fluids for studies of disease-associated protein biomarkersCirculating matrix metalloproteinases in children with diabetic ketoacidosis.Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview.Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group.Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in the tumors of central nervous system (CNS).Isothermal vitrification methodology development for non-cryogenic storage of archival human sera.Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships.Matrix Metalloproteinases in Alzheimer's Disease and Concurrent Cerebral Microbleeds.Systemic matrix metalloproteinase-8 and tissue inhibitor of metalloproteinases-1 levels in severe sepsis-associated coagulopathy.The Sample Type used Affects the Levels of Gelatinases (MMP-2 and -9) and their Inhibitors (TIMP-1 and -2) in Circulating Blood of Healthy Controls and Breast Cancer Patients.Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals.Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne.Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study.Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas.Matrix metalloprotease-2 and -9 concentration and activity in serum and culture medium samples: a methodological reappraisal.Impact of cryopreservation on serum concentration of matrix metalloproteinases (MMP)-7, TIMP-1, vascular growth factors (VEGF) and VEGF-R2 in Biobank samples.Stability of matrix metalloproteinase-9 as biological marker in colorectal cancer.Circulating matrix metalloproteinases and their tissue inhibitors as markers for ethnic variation in pelvic floor tissue integrity
P2860
Q27001736-EC3B3865-DEB0-4441-BA80-9C9008212365Q30433587-1EF21102-C93A-4AA7-93E7-5C07791A45FEQ30925905-2A21ECA0-EE4E-439D-ABDA-B024844C540DQ33323378-7805CD70-0B93-4DB1-A572-22997D2561FEQ33809526-1EA381A3-DE39-46A3-82C3-66FE24C55203Q34222299-CC41D7B9-DCBD-4935-B10C-94288594C344Q34473927-D9B21D65-0B54-41C2-B2AE-1BDAB2525E07Q34635975-0E73D879-D5FC-488E-BC72-5FF684A610C3Q35781795-84F6CF27-C8C4-42C1-85CC-160CC928BE31Q36789976-5EF87831-C359-40B3-8BF5-77292E00537DQ36858663-53A46CE1-BBBA-4D11-9864-15C2A16BA9DFQ36919974-2AB8C849-59FF-463F-8D67-1CEB98229AA0Q37153161-130A8444-A195-40DA-9B97-B66721EC50E1Q37412311-C78E90D8-341A-43FE-9C4A-F8365E6DDB0AQ37824829-3273A033-08A1-47B4-AE4B-A51D3C465748Q38063697-D72B5A4B-194E-4ACE-82D8-3ECBA5B92845Q38173695-19D33D36-D04A-4F02-AED7-A3047E62C961Q38398370-0FB09646-F32D-4569-B212-6F9F3A6DE14BQ40097601-6C07E272-5060-4655-9FD2-D46ADD285FF8Q41324589-C6DA823B-2BE8-4C48-BC3B-30E3C86CFDFBQ41695234-14567315-C407-4F01-B105-A852EAAA009CQ42617736-E1333E14-E051-4064-88B4-F455D67B871DQ44511702-306999EC-A1E3-47E1-A9D3-E48954D7501DQ47115483-E7AB48B4-68CD-40B0-BED0-3679DA5F0870Q47960038-E7D61618-336F-4A5E-9380-901BFB3D61C1Q49118867-6D9332E2-818A-44A8-B145-B7BA03845BE7Q50776557-6B190DCE-0F7F-4358-850F-D44ED98DBCC5Q51629440-498CA87D-A4F0-4CD3-872C-34F22F0CAAB9Q54972156-E9E7BEBD-EED7-49DC-B3B7-63BFE00FDF77Q57120122-3F4D8503-11C3-4FB6-8F58-6AB5341B0F4D
P2860
Plasma storage at -80 degrees C does not protect matrix metalloproteinase-9 from degradation.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Plasma storage at -80 degrees ...... proteinase-9 from degradation.
@ast
Plasma storage at -80 degrees ...... proteinase-9 from degradation.
@en
type
label
Plasma storage at -80 degrees ...... proteinase-9 from degradation.
@ast
Plasma storage at -80 degrees ...... proteinase-9 from degradation.
@en
prefLabel
Plasma storage at -80 degrees ...... proteinase-9 from degradation.
@ast
Plasma storage at -80 degrees ...... proteinase-9 from degradation.
@en
P2093
P356
P1476
Plasma storage at -80 degrees ...... proteinase-9 from degradation.
@en
P2093
Céline Jeanty
Daniel R Wagner
Didier Rouy
Isabelle Ernens
P304
P356
10.1016/J.AB.2004.10.052
P407
P577
2005-03-01T00:00:00Z